Found 4 matching trials
Evaluating the Safety and Immunogenicity of HIV-1 BG505 SOSIP.664 gp140 With TLR Agonist and/or Alum Adjuvants in Healthy, HIV-uninfected Adults
PHASE1The purpose of this study is to evaluate the safety and immunogenicity of H...
Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted
PHASE1Despite having developed robust acquired immunity against complications of ...
Location
Institut de Recherche Clinique du Benin (IRCB)
rCSP/AP10-602 [GLA-LSQ] Vaccine Trial
PHASE1This is a study to evaluate the safety, immunogenicity, and efficacy of a r...
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Pan-Malaria Transmission-Blocking Vaccine AnAPN1
PHASE1Malaria is still responsible for more than 627,000 deaths each year, predom...
Location
Centre de Recherches Médicales de Lammbaréné